Comparison of a radiolabeled somatostatin agonist with an antagonist using the SSTR2 expressing cell line BON-1S in 2D and 3D models

Objective: The somatostatin receptor subtype 2 (SSTR2) is a suitable target for the diagnosis and therapy of neuroendocrine tumors using radiolabeled ligands [1]. BON-1S cells have been described to express SSTR2 receptors in vitro [2]. We therefore established 2D and 3D cell culture systems of BON-1S cells. For SSTR2 ligand binding, BON-1S cells cultured as monolayer or spheroids were incubated with an SSTR2 agonist (NODAGA-TATE) or an SSTR2 antagonist (NODAGA-JR11). Both were labeled with either 68Ga- or 64Cu and their respective binding and uptake were determined. Understanding the binding data is a prerequisite for using spheroids of BON-1S cells in a
Micro Physiological System (MPS) [3].
Methods: Spheroids of SSTR2 containing BON-1S cells were created as follows: Freshly harvested cells were incubated with magnetic nanoparticles in RPMI medium overnight. After magnetic particle uptake, cells were split into a 24-well-plate (1.5 x 10-4 cells/well). In an incubator, the magnetic particles were moved via a magnetic drive for five days, to allow the formation of spheroids [4]. After incubation with the 68Ga- or 64Cu-labeled radioligands (RCY>95%), the BON-1S cells, either as monolayer or as spheroids, were washed and treated with acidic glycine buffer (pH 3.0) to remove the bound but not yet internalized molecules from the outer cellular membrane.
After this washing step, the remaining radioligand molecules are assumed to represent internalized molecules [5]. In the monolayer,
internalization was determined after 10 minutes, 1 hour and 3 hours after addition of the radioligand to the respective culture.
Results: Saturation analysis of radiolabeled NODAGA-TATE as well as NODAGA-JR11 on BON-S1 monolayer yielded similar Kd values in the low nanomolar range (2.3 to 8.6 nM). Affinity of the respective radiolabeled ligand was much lower on BON-1S spheroids, with Kd values around 30 nM for both 64Cu-labeled ligands and almost 60 nM for the 68Ga-labeled ligands. The maximal binding capacity (Bmax) was higher on monolayers and spheroids for radiolabeled JR11 (NODAGA-TATE: monolayer 0.3 pmol/mg, spheroids 0.8 pmol/mg; NODAGA-JR11: monolayer and spheroids 1.2 pmol/mg). The internalization assay showed a ratio of internalized to surface bound radiolabeled NODAGA-TATE of about 80% to 20% for both forms of cell culture, for radiolabeled JR11 a ratio of 8% to 92% was determined, each after a 60 min-incubation time. The internalization after the three time points was ca. 10 times lower in case of radiolabeled JR11 (0.25% (TATE) versus maximal 0.03% (JR11) of administered activity amount/µg protein).
Conclusions: Using monolayer or spheroids of BON-1S cells (the latter were generated by the iron nanoparticle method) we could
estimate reliable and reproducible binding parameters for a radiolabeled agonist and antagonist of SSTR2. There are obvious differences in binding affinities of the examined radiolabeled conjugates in monolayer cell culture compared to the spheroids.
Acknowledgements: The SSTR2 expressing BON-1S cells were kindly given by Prof. Dr. Wiedenmann, University Hospital Charité
Berlin.
References:
[1] Eychenne, Molecules 2020, 25, 4012.
[2] Exner, Front Endocrinol 2018, 9, 146.
[3] Busek, J Sens Sens Syst 2016, 5, 228.
[4] Noel, J Vis Exp 2017, 126, e56081.
[5] Matzku, Cancer Res 1986, 46, 3848.